Colorado State University is among the world's leaders in researching West Nile Virus, drug-resistant Tuberculosis, Yellow Fever, Dengue, Hantavirus, Plague, Tularemia and other diseases.
BioMARC was created to fill an industry need for higher containment biologics manufacturing (BSL-3 and Select Agent cGMP manufacturing). BioMARC full time staff of manufacturing experts, best practice methodology and adherence to quality and validation practices along with their extensive network of professionals throughout CSU provides the foundation for which their Contract Manufacturing Organization (CMO) operates.
The Research Innovation Center (RIC) serves as a vehicle to perform collaborative translational-stage research with CSU's life sciences community of researchers, giving it the promise to become the birthplace of medical breakthroughs.
Next generation sequencing is a new technology with tremendous potential for new discovery in multiple biological science disciplines and is setting a new standard in genomic-based investigations. This technology enables massively parallel sequencing of nucleic acid fragments to address a variety of experimental questions including DNA sequencing and whole transcriptome analysis.
The mission of the Infectious Disease Supercluster (IDSC) is to develop and implement effective interventions for human, animal, and plant infectious diseases of global importance. The ID SC provides an organizational framework to integrate, mobilize, and develop CSU talents, resources, and infrastructure to help reduce the terrible global burden of infectious diseases and to overcome barriers to international trade of agricultural products due to infectious diseases. Learn More
Who We Are
The Infectious Disease Research Center provides a safe, secure, state of art facility for university investigators, government scientists and industry representatives to collaboratively research the basic biology, biochemistry, molecular biology and epidemiology of bacteria and viruses that cause human and animal diseases. The Center provides the highest quality research environment for developing new scientific discoveries, vaccines, methods of diagnosis, and therapeutic agents for infectious agents.
To provide outstanding service to research and small business customers through laboratory maintenance, maintenance of relevant specialized services and providing access to new opportunities in order to support and enhance their ability to meet their research goals.
Announcements & News
- Recorded Seminars
- Sept-20, Dr. Patrick Iversen, Emerging RNA Therapeutics for Infectious Disease and Beyond
- Mar-28, Dr. Rebekah Kading, Search for New Viruses in Bats in Uganda and Kenya
- May-6, Dr. Roy Hall, Discovery of new mosquito-borne viruses in Australia and their role in vector-borne disease
- May-30, Dr. William Nicholson, Heartland Virus
- Message from the Director
- Next Generation Sequencing Core
- Organizational Chart
- Rates, Fees, and Service Provided
- Research Innovation Center (RIC)
- Current Job Openings
- Bio/Pharmaceutical Production Specialist I
- Bio/Pharmaceutical Manager (Project Manager)
- Bio/Pharmaceutical Quality Assurance Supervisor/Manager
- Bio/Pharmaceutical FOV Technician/Manager
- IDRC Building Operations Manager
- IDRC Next Generation Sequencing Research Associate I
- IDRC Barrier Maintenance Technician (BMT)